EVAX · NASDAQ · Biotechnology

Evaxion (ADR) (EVAX)

Decodes immune biology with AI to build vaccine candidates and partner programs.

$3.00
Pre-market−0.09 (−3.05%)
At close$3.10(+3.86%)

Something off on this page? Send us feedback.

Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.01
Revenue estimate
$300.0K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Aug '25Nov '25Mar '26May '26May '26Aug '26Aug '26Nov '26
Reported−$0.76$0.73−$1.00−$0.44−$0.01−$0.01−$0.01Pending
Estimate−$0.50−$0.25−$0.01−$0.01−$0.01−$0.01−$0.01
Surprise−52.0%−308.2%−4,300.0%0.0%0.0%0.0%

RevenueReportedEstimate

Aug '25Nov '25Mar '26May '26May '26Aug '26Aug '26Nov '26
Reported$37.0K$7.5MPending
Estimate$8.0M$7.5M$9.2M$9.2M$6.7M$6.7M$300.0K
Surprise−99.5%

History

DateEstimateReportedSurprise
Nov 2026−$0.01
Aug 2026−$0.01−$0.010.0%
Aug 2026−$0.01−$0.010.0%
May 2026−$0.01−$0.010.0%
May 2026−$0.01−$0.44−4,300.0%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Mar 2026
Nov 2025
Aug 2025
May 2025
Mar 2025
Oct 2024
Aug 2024
May 2024
Mar 2024
Dec 2023
Aug 2023
May 2023
Apr 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Apr 2021
Nov 2020
Jul 2020
Apr 2020
Dec 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 5, 2026−$0.01$300.0K
Aug 20, 2026−$0.01−$0.010.0%$6.7M+4.1%
Aug 13, 2026−$0.01−$0.010.0%$6.7M+4.6%
May 26, 2026−$0.01−$0.010.0%$9.2M−1.2%
May 7, 2026−$0.01−$0.44−4,300.0%$9.2M+6.6%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Mar 5, 2026
Nov 6, 2025
Aug 14, 2025
May 27, 2025
Mar 26, 2025
Oct 31, 2024
Aug 14, 2024
May 28, 2024
Mar 27, 2024
Dec 19, 2023
Aug 18, 2023
May 31, 2023
Apr 27, 2023
Mar 28, 2023
Nov 14, 2022
Aug 10, 2022
May 11, 2022
Mar 22, 2022
Nov 9, 2021
Aug 12, 2021
May 13, 2021
Apr 6, 2021
Nov 5, 2020
Jul 5, 2020
Apr 5, 2020
Dec 31, 2019